Logo image of CETX

CEMTREX INC (CETX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CETX - US15130G8731 - Common Stock

2.28 USD
-0.17 (-6.94%)
Last: 1/16/2026, 8:00:00 PM
2.32 USD
+0.04 (+1.75%)
After Hours: 1/16/2026, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, CETX scores 2 out of 10 in our fundamental rating. CETX was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. CETX may be in some trouble as it scores bad on both profitability and health. CETX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CETX had negative earnings in the past year.
  • In the past year CETX had a positive cash flow from operations.
  • CETX had negative earnings in each of the past 5 years.
  • In the past 5 years CETX reported 4 times negative operating cash flow.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M

1.2 Ratios

  • CETX's Return On Assets of -59.34% is on the low side compared to the rest of the industry. CETX is outperformed by 82.54% of its industry peers.
  • With a Return On Equity value of -325.30%, CETX is not doing good in the industry: 91.27% of the companies in the same industry are doing better.
  • CETX's Return On Invested Capital of 1.69% is in line compared to the rest of the industry. CETX outperforms 52.38% of its industry peers.
Industry RankSector Rank
ROA -59.34%
ROE -325.3%
ROIC 1.69%
ROA(3y)-31.62%
ROA(5y)-27.6%
ROE(3y)-199.93%
ROE(5y)-145.51%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • CETX's Operating Margin of 0.67% is in line compared to the rest of the industry. CETX outperforms 49.21% of its industry peers.
  • CETX has a Gross Margin of 42.21%. This is in the better half of the industry: CETX outperforms 72.22% of its industry peers.
  • In the last couple of years the Gross Margin of CETX has remained more or less at the same level.
Industry RankSector Rank
OM 0.67%
PM (TTM) N/A
GM 42.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y0.85%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CETX is destroying value.
  • The number of shares outstanding for CETX has been increased compared to 1 year ago.
  • The number of shares outstanding for CETX has been increased compared to 5 years ago.
  • The debt/assets ratio for CETX has been reduced compared to a year ago.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200K 400K 600K 800K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -1.12, we must say that CETX is in the distress zone and has some risk of bankruptcy.
  • CETX has a worse Altman-Z score (-1.12) than 80.16% of its industry peers.
  • CETX has a Debt/Equity ratio of 0.53. This is a neutral value indicating CETX is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.53, CETX is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACC0.32
WACC5.21%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • CETX has a Current Ratio of 1.22. This is a normal value and indicates that CETX is financially healthy and should not expect problems in meeting its short term obligations.
  • CETX has a worse Current ratio (1.22) than 82.54% of its industry peers.
  • CETX has a Quick Ratio of 1.22. This is a bad value and indicates that CETX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.94, CETX is doing worse than 80.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.94
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 97.65% over the past year.
  • The Revenue has grown by 14.39% in the past year. This is quite good.
  • CETX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.95% yearly.
EPS 1Y (TTM)97.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.62%
Revenue 1Y (TTM)14.39%
Revenue growth 3Y14.99%
Revenue growth 5Y11.95%
Sales Q2Q%2.16%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y265.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2023 2024 2025 2026 0 2M -2M 4M -4M -6M

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 1.11, the valuation of CETX can be described as very cheap.
  • 100.00% of the companies in the same industry are more expensive than CETX, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CETX to the average of the S&P500 Index (24.29), we can say CETX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.11
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • 97.62% of the companies in the same industry are more expensive than CETX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.18
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100 -200

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CEMTREX INC

NASDAQ:CETX (1/16/2026, 8:00:00 PM)

After market: 2.32 +0.04 (+1.75%)

2.28

-0.17 (-6.94%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)12-29
Earnings (Next)02-12
Inst Owners0.36%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change0%
Market Cap1.69M
Revenue(TTM)76.49M
Net Income(TTM)-28.36M
Analysts82.86
Price TargetN/A
Short Float %40.6%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.11
P/S 0.02
P/FCF N/A
P/OCF 10.59
P/B 0.19
P/tB 0.44
EV/EBITDA 7.18
EPS(TTM)-241.29
EYN/A
EPS(NY)2.05
Fwd EY89.92%
FCF(TTM)-3.74
FCFYN/A
OCF(TTM)0.22
OCFY9.44%
SpS103.36
BVpS11.78
TBVpS5.2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -59.34%
ROE -325.3%
ROCE 2.13%
ROIC 1.69%
ROICexc 2.13%
ROICexgc 2.86%
OM 0.67%
PM (TTM) N/A
GM 42.21%
FCFM N/A
ROA(3y)-31.62%
ROA(5y)-27.6%
ROE(3y)-199.93%
ROE(5y)-145.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y0.85%
F-Score5
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Debt/EBITDA 2.46
Cap/Depr 216.16%
Cap/Sales 3.83%
Interest Coverage 0.5
Cash Conversion 8.53%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.94
Altman-Z -1.12
F-Score5
WACC5.21%
ROIC/WACC0.32
Cap/Depr(3y)194.3%
Cap/Depr(5y)152.34%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.62%
EPS Next Y265.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.39%
Revenue growth 3Y14.99%
Revenue growth 5Y11.95%
Sales Q2Q%2.16%
Revenue Next Year15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y110.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.03%
OCF growth 3YN/A
OCF growth 5YN/A

CEMTREX INC / CETX FAQ

Can you provide the ChartMill fundamental rating for CEMTREX INC?

ChartMill assigns a fundamental rating of 2 / 10 to CETX.


Can you provide the valuation status for CEMTREX INC?

ChartMill assigns a valuation rating of 4 / 10 to CEMTREX INC (CETX). This can be considered as Fairly Valued.


Can you provide the profitability details for CEMTREX INC?

CEMTREX INC (CETX) has a profitability rating of 2 / 10.


How financially healthy is CEMTREX INC?

The financial health rating of CEMTREX INC (CETX) is 1 / 10.


Can you provide the expected EPS growth for CETX stock?

The Earnings per Share (EPS) of CEMTREX INC (CETX) is expected to grow by 265.45% in the next year.